SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000897204-19-000013
Filing Date
2019-02-08
Accepted
2019-02-08 16:08:22
Documents
1

Document Format Files

Seq Description Document Type Size
1 GENEXTRA SCHEDULE 13G/A schedule13ga.htm SC 13G/A 43087
  Complete submission text file 0000897204-19-000013.txt   44631
Mailing Address 10 HUDSON YARDS, 37TH FLOOR New York NY 10001
Business Address 10 HUDSON YARDS, 37TH FLOOR NEW YORK NY 10001 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Subject) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87033 | Film No.: 19579951
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address VIA G. DE GRASSI, 11 MILAN L6 20123
Business Address VIA G. DE GRASSI, 11 MILAN L6 20123 390236515110
Genextra S.p.A. (Filed by) CIK: 0001559515 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L6 | Fiscal Year End: 1212
Type: SC 13G/A